Newsroom
Sorted by: Latest
-
SynergenX, Low T Center and HerKare Clinics Unite Under the SynergenX Brand
HOUSTON--(BUSINESS WIRE)--SynergenX announced today that its Low T Center and HerKare clinics will begin transitioning under one unified brand identity over the coming year, reflecting the organization’s continued commitment to helping patients live healthier, more confident, and more fulfilling lives. Though the company will be unveiling an exciting new logo and updated marketing materials, this transition represents more than a visual evolution. It reflects a broader philosophy of care center...
-
Sable Offshore Corp. to Host Conference Call on June 12, 2026
HOUSTON--(BUSINESS WIRE)--Sable Offshore Corp. to Host Conference Call on June 12, 2026...
-
Faraday Future Announces the Launch of Its EAI Robotics Education Ecosystem Strategy, Product Line & New EAI Device Launch being held on June 16, 2026
LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today announced additional details for its FF EAI Robotics Education Ecosystem Strategy, Product Line & New EAI Device Launch being held on June 16, 2026, at the Company’s Los Angeles headquarters. FF is inviting those interested in this momentous occasion to join the Company in person or online for th...
-
AM Best Affirms Issue Credit Rating of Weston2044 LLC Series Hannover, No. 1 Variable Funding Credit Linked Note
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Long-Term Issue Credit Rating (Long-Term IR) of “a” (Excellent) on the $1.654 billion (which upsized to $1.805 billion outstanding as of March 31, 2026), 6.00% Series Hannover, No. 1 variable funding credit-linked note (note), due Oct. 1, 2044, of Weston2044 LLC (Weston2044), a Delaware limited liability company (issuer). The outlook of this Credit Rating (rating) is stable. The note is in consideration of a variable funding surplus note...
-
Pleo annonce de nouvelles fonctionnalités d'Agentic, qui révolutionnent la gestion financière et la prise de décision
LONDRES--(BUSINESS WIRE)--Pleo, la plateforme européenne de référence en matière de finance stratégique, annonce aujourd'hui le lancement d'une suite d'agents IA capables de gérer de manière autonome les dépenses courantes, permettant ainsi aux responsables financiers de se concentrer sur la prise de décision plutôt que sur les tâches administratives. Les équipes financières subissent une pression croissante : 45 % des entreprises européennes affirment que leurs processus actuels les ralentisse...
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that on June 10, 2026, the Compensation Committee of its Board of Directors granted inducement equity grants to six new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 32,000 shares of its common stock. These inducement RSUs are subject to the terms of Travere’s 2018 Equity Incentive Plan (“2018 Plan”) but were granted outside of the 2018 Plan and were granted as i...
-
Venture Global Announces Closing of $2.25 Billion of Senior Secured Notes
ARLINGTON, Va.--(BUSINESS WIRE)--Venture Global Announces Closing of $2.25 Billion of Senior Secured Notes...
-
REMEDY Raises Series A Led by L Catterton to Modernize Dermatologist-Developed Skincare
LOS ANGELES--(BUSINESS WIRE)--Remedy Science (“REMEDY”), the dermatologist-developed, education-first skincare brand translating clinical expertise into accessible, high-performance products, today announced the closing of its Series A funding round led by L Catterton, the largest global consumer-focused investment firm, with participation from existing investor Norwest and new investor Sonoma Brands Capital. Founded by board-certified dermatologist Dr. Muneeb Shah, REMEDY was created to mirror...
-
Samenvatting: Pleo kondigt nieuwe agentic capaciteiten aan, die het aspect van financieel management en beslissingname veranderen
LONDEN--(BUSINESS WIRE)--Pleo, Europa's eerste en meest vertrouwde platform voor strategische finance, kondigde vandaag een reeks AI agents aan die routine uitgavenbeheer autonoom afhandelen, zodat finance leiders hun aandacht kunnen toespitsen op beslissingen in plaats van hun tijd aan administratieve taken te besteden. Finance teams staan steeds meer onder druk: 45% van de Europese bedrijven geeft aan dat hun huidige processen hen afremmen, en leiders beschrijven goedkeuringsworkflows als zo...
-
Pleo transformiert Finanzmanagement und Entscheidungsfindung durch neue KI-Agentenfunktionen
LONDON--(BUSINESS WIRE)--Pleo, Europas erste und vertrauenswürdigste Plattform für strategisches Finanzmanagement, präsentiert heute mehrere KI-Agenten, die das routinemäßige Ausgabenmanagement selbstständig durchführen, damit Finanzverantwortliche ihren Fokus auf wichtige Entscheidungen statt auf administrative Aufgaben legen können. Finanzteams sind einem wachsenden Druck ausgesetzt: 45 % der europäischen Unternehmen fühlen sich durch ihre derzeitigen Prozesse ausgebremst. Führungskräfte betr...